CCM
TMDX icon

Coldstream Capital Management’s Transmedics TMDX Stock Holding History

Coldstream Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,747
Closed -$213K – 1261
2025
Q4 		$213K Buy
+1,747
New +$219K ﹤0.01% 1069
2025
Q2 		– Sell
-1,314
Closed -$88.4K – 3160
2025
Q1 		$88.4K Buy
+1,314
New +$90.4K ﹤0.01% 1420

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Coldstream Capital Management's TMDX Position: Q1 2026 in Review

Coldstream Capital Management sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 1,747 shares — an estimated $213K sold.

Coldstream Capital Management first reported a position in TMDX in Q1 2025 and held it in 2 quarters. The position peaked at $213K in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Coldstream Capital Management reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Coldstream Capital Management sold 1,747 Transmedics shares in Q1 2026, an estimated $213K.
  • Coldstream Capital Management first reported a position in Transmedics in Q1 2025 and held it in 2 quarters.
  • Coldstream Capital Management's Transmedics position peaked at $213K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.